Browsing by Author Sandhu, Shahneen

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2014Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanomaLong, Georgina; Bowyer, Samantha; Hicks, Rodney J; Lyle, Megan; McArthur, Grant A.; Millward, Michael; Raleigh, Jeanette; Rao, Aparna; Sandhu, Shahneen; Central Clinical School: The Sydney Cancer CentreActivity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanoma, Melanoma Research, vol.24, 5, 2014,pp 504-508
2017Safety and Efficacy Implications of Discontinuing Combination Ipilimumab and Nivolumab in Advanced MelanomaCarlino, Matteo; Sandhu, Shahneen; Westmead Clinical School: MedicineSafety and Efficacy Implications of Discontinuing Combination Ipilimumab and Nivolumab in Advanced Melanoma, American Journal of Clinical Oncology, vol.35, 34, 2017,pp 3792-3793
2017When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the Australian guidelines for the management of cutaneous melanoma'Thompson, John; Barbour, Andrew; Gyorki, David; Hanikeri, Mark; Mar, Victoria; Sandhu, Shahneen; Central Clinical School: SurgeryWhen is a sentinel node biopsy indicated for patients with primary melanoma? An update of the Australian guidelines for the management of cutaneous melanoma', Australasian Journal of Dermatology, vol.58, 4, 2017,pp 274-277